Litigation Details for Hospira, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2017)

Hospira, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2017)

Docket		Date Filed	2017-11-01
Court	District Court, N.D. Illinois	Date Terminated	2018-12-17
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Patents	8,242,158; 8,338,470; 8,455,527; 8,648,106; 9,320,712; 9,616,049
Link to Docket	External link to docket

Details for Hospira, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-11-01	1		infringement of U.S. Patent No. 9,616,049 (the “’049 patent”) (Ex. A) (the “Patent-in-suit”). … COUNT I FOR INFRINGEMENT OF PATENT NO. 9,616,049 17. Paragraphs 1 through… THE PATENT-IN-SUIT 9. The ’049 patent, entitled “Dexmedetomidine…assignee and owner of the ’049 patent. 10. The Patent-in-suit is duly listed in the… 4. This action is based upon the Patent Laws of the United States, 35 U.S.C. § 1 et seq	External link to document
2018-12-16	109	Order on Motion for Partial Summary Judgment	obtained four patents covering a new product made from dexmedetomidine: U.S. Patent Nos. 8,242,158 (the “’158…’158 Patent”), 8,338,470 (the “’470 Patent”), 8,455,527 (the “’527 Patent”), and 8,648,106 (the “’106…product—U.S. Patent No. 9,616,049 (the “’049 Patent”)—and filed a second complaint of patent infringement…obtained a patent that disclosed and claimed the compound: U.S. Patent No. 4,910,214 (the “’214 Patent”), JTX…named co- inventors of the patents-in-suit. (See ’106 Patent, JTX 1; ’049 Patent, JTX 2.) Dr. Roychowdhury	External link to document